SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020 - 2021)
SOPHiA GENETICS's (SOPH) quarterly Non-Current Deffered Revenue came in at $134000.0 in Q3 2021, down 2.9% quarter-over-quarter from $138000.0 in Q2 2021.
SOPHiA GENETICS (SOPH) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
SOPHiA GENETICS has disclosed Non-Current Deffered Revenue across 2 years of filings, most recently posting $134000.0 for Q3 2021.
- Non-Current Deffered Revenue for Q3 2021 came in at $134000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2021 was $134000.0 (changed N/A YoY), and the FY2020 annual result was $142000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $134000.0 for Q3 2021 at SOPHiA GENETICS, down from $138000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $142000.0 in Q4 2020 to a low of $134000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 4.57 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 10.14 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 400,000.00 |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 5.16 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 63.07 Mn |
| 10 | SOPHiA GENETICS | 26.19 Mn | -44.10 Mn | 14.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 134,000.00 |
| Jun 30, 2021 | 138,000.00 |
| Dec 31, 2020 | 142,000.00 |